DexCom Inc (DXCM)

NASDAQ
Currency in USD
Disclaimer
93.30
-2.16(-2.26%)
Closed
After Hours
93.31+0.01(+0.01%)
Day's Range
93.1397.58
52 wk Range
81.06139.55
Prev. Close
95.46
Open
97.37
Day's Range
93.13-97.58
52 wk Range
81.06-139.55
Volume
5,363,307
Average Vol. (3m)
3,801,643
1-Year Change
13.64%
Shares Outstanding
387,871,796
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
142.12
Upside +52.33%

People Also Watch

458.66
KLAC
+0.12%
53.52
ARM
-3.55%
58.68
FTNT
+0.14%
434.99
NVDA
+0.95%
305.32
ALGN
-0.71%

DexCom Inc Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Income Statement